Murchinson’s Lexaria Bioscience LEXX Stock Holding History

Murchinson’s Portfolio LEXX Stock Details LEXX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-27,973	Closed	-$400K	–	101
2025 Q3	$400K	Buy	+27,973	New	+$406K	0.05%	72

Other funds holding LEXX

ICM

Invenomic Capital Management Boston, Massachusetts $1.67B AUM 1.43% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $86.4B AUM 59.51% 1-Year Est. Return

BAM

Byrne Asset Management Kingston, New Jersey $185M AUM 41.05% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Krilogy Financial St. Louis, Missouri $3.38B AUM 30.57% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Murchinson's LEXX Position: Q4 2025 in Review

Murchinson sold out of Lexaria Bioscience (LEXX) in Q4 2025, closing a stake of 27,973 shares — an estimated $400K sold.

Murchinson first reported a position in LEXX in Q3 2025 and held it in 1 quarter. The position peaked at $400K in Q3 2025. 20 funds tracked by Wall St. Rank hold LEXX as of Q4 2025.

Murchinson reported no remaining Lexaria Bioscience position as of Q4 2025 after selling out during the quarter.
Murchinson sold 27,973 Lexaria Bioscience shares in Q4 2025, an estimated $400K.
Murchinson first reported a position in Lexaria Bioscience in Q3 2025 and held it in 1 quarter.
Murchinson's Lexaria Bioscience position peaked at $400K in Q3 2025.
20 funds tracked by Wall St. Rank held Lexaria Bioscience as of Q4 2025.

Based on Murchinson's 13F filing for Q4 2025, filed 17 Feb 2026.